卡巴克络磺酸钠在全膝关节置换术中的止血与抗炎效果:随机对照试验
本研究为随机安慰剂对照试验,纳入200例单侧初次全膝关节置换术患者,分为四组:A组接受氨甲环酸(TXA)联合局部及静脉卡巴克络磺酸钠(CSS),B组接受TXA联合局部CSS,C组接受TXA联合静脉CSS,D组仅接受TXA。结果显示,A、B、C组总失血量均低于D组,且A、B、C组在术后肿胀率、炎症生物标志物水平、视觉模拟量表疼痛评分及出院时关节活动度方面均较D组显著改善;四组在输血率、术中失血量、血小板计数或平均住院时间方面无差异,无血栓栓塞并发症发生。
要点
- CSS联合TXA较单用TXA更有效减少围手术期失血和炎症反应。
- A、B、C组总失血量均低于D组,B组与C组间无差异。
- 联合方案未增加血栓栓塞并发症发生率。
核心结论
- CSS联合TXA在减少围手术期失血和炎症反应方面比单用TXA更有效,且未增加血栓栓塞并发症的发生率。
研究设计与样本
- 随机安慰剂对照试验,纳入200例接受单侧初次全膝关节置换术的患者,分为4组:A组接受TXA联合局部及静脉CSS,B组接受TXA联合局部CSS,C组接受TXA联合静脉CSS,D组仅接受TXA。
主要发现
- A组总失血量为609.92 ± 221.24 mL,B组为753.16 ± 247.67 mL,C组为829.23 ± 297.45 mL,均低于D组的1158.26 ± 334.13 mL(P < .05)。
- B组与C组之间总失血量无差异。
- 与D组相比,A、B、C组的术后肿胀率、炎症生物标志物水平、视觉模拟量表疼痛评分及出院时关节活动度均显著改善(P < .05)。
- 四组在输血率、术中失血量、血小板计数或平均住院时间方面无差异(P > .05)。
- 无血栓栓塞并发症发生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative recovery after total knee arthroplasty (TKA) is associated with postoperative anemia, allogeneic transfusion, and stress immune responses to surgery. Carbazochrome sodium sulfonate (CSS) reduces bleeding through several mechanisms. We assessed the effect of CSS combined with tranexamic acid (TXA) on postoperative anemia, blood transfusion, and inflammatory responses. METHODS: This study was designed as a randomized, placebo-controlled trial of 200 patients undergoing unilateral primary TKA. Patients were divided into 4 groups: group A received TXA plus topical and intravenous CSS; group B received TXA plus topical CSS only; group C received TXA plus intravenous CSS only; group D received TXA only. RESULTS: Total blood loss in groups A (609.92 ± 221.24 mL), B (753.16 ± 247.67 mL), and C (829.23 ± 297.45 mL) was lower than in group D (1158.26 ± 334.13 mL, P < .05). There was no difference in total blood loss between groups B and C. We also found that compared with group D, the postoperative swelling rate, biomarker level of inflammation, visual analog scale pain score, and range of motion at discharge in groups A, B, and C were significantly improved (P < .05). No thromboembolic complications occurred. There were no differences in transfusion rate, intraoperative blood loss, platelet count, or average length of stay among the 4 groups (P > .05). CONCLUSION: CSS combined with TXA was more effective than TXA alone in reducing perioperative blood loss and inflammatory response and did not increase the incidence of thromboembolism complications.
引用
- Luo Y, Zhao X, Releken Y, et al. Hemostatic and Anti-Inflammatory Effects of Carbazochrome Sodium Sulfonate in Patients Undergoing Total Knee Arthroplasty: A Randomized Controlled Trial. J Arthroplasty. 2019. PMID: 31471180. doi:10.1016/j.arth.2019.07.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。